Valuation: Azenta, Inc.

Market Cap 1.6B 8.07B 1.43B 1.33B 1.21B 2.27B 152B 2.31B 15.94B 6.24B 79.06B 6B 5.88B 253B P/E 2026 *
-10.1x
P/E 2027 * 96.1x
Enterprise Value 1.6B 8.07B 1.43B 1.33B 1.21B 2.27B 152B 2.31B 15.94B 6.24B 79.06B 6B 5.88B 253B EV / Sales 2026 *
2.6x
EV / Sales 2027 * 2.51x
Free-Float
75.47%
Yield 2026 *
-
Yield 2027 * -
1 day-4.05%
1 week+2.16%
Current month+3.34%
1 month+4.62%
3 months+57.75%
6 months+61.45%
Current year-2.94%
1 week 15
Extreme 15
15.8
1 month 14.14
Extreme 14.14
18.46
Current year 8.9
Extreme 8.9
18.46
1 year 8.9
Extreme 8.9
18.46
3 years 8.9
Extreme 8.9
29.07
5 years 8.9
Extreme 8.9
40.04
10 years 8.9
Extreme 8.9
40.04
Manager TitleAgeSince
Chief Executive Officer 66 2026-08-21
Director of Finance/CFO 49 2024-11-30
Chief Tech/Sci/R&D Officer - 2017-06-30
Director TitleAgeSince
Director/Board Member 64 2013-06-27
Director/Board Member 50 2020-04-02
Chairman 72 2024-01-29
Change 5-day change 1-year change 3-year change Capi.($)
-4.05%+2.16% - - 1.63B
+0.21%-4.63%+55.34%+71.32% 68.92B
+1.66%+7.51%+8.12%+60.04% 51.9B
+3.14%+7.17%+12.48%+44.42% 48.73B
+3.45%+4.70%+33.44%+35.96% 43.13B
-2.20%+0.61%+281.88%+532.76% 41.48B
+6.43%+6.84%+18.32%+109.23% 39.96B
+1.28%+1.39%+11.69%+45.10% 30.6B
+2.43%-7.37%+36.06%+1.80% 26.01B
+1.74%-2.02%-13.55%-12.92% 22.27B
Average +1.42%-0.94%+49.31%+98.63% 41.44B
Weighted average by Cap. +1.88%-0.25%+52.82%+105.49%

Financials

2026 *2027 *
Net sales 615M 3.1B 549M 510M 464M 873M 58.24B 889M 6.13B 2.4B 30.38B 2.31B 2.26B 97.23B 638M 3.22B 570M 530M 482M 906M 60.46B 923M 6.36B 2.49B 31.54B 2.4B 2.34B 101B
Net income -166M -839M -148M -138M -126M -236M -15.76B -240M -1.66B -649M -8.22B -624M -611M -26.31B 16.3M 82.19M 14.55M 13.52M 12.3M 23.14M 1.54B 23.56M 162M 63.55M 806M 61.17M 59.87M 2.58B
Net Debt - -
Projected Income Statement - Annual - Azenta, Inc.
Logo Azenta, Inc.
Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.
Employees
2,900
Date Price Change Volume
26-10-15 R$15.16 -4.05% 874
26-10-13 R$15.80 +6.47% 3
26-10-08 R$14.84 -3.26% 1
26-10-07 R$15.34 -7.81% 1,451
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Azenta, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
36.52USD
Average target price
39.00USD
Spread / Average Target
+6.79%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Azenta, Inc.